Status:
COMPLETED
Multi-center Research Project for Glioma Molecular Pathology Intraoperative Rapid Detection
Lead Sponsor:
Jinsong Wu
Conditions:
Glioma, Malignant
Eligibility:
All Genders
18-80 years
Brief Summary
We explores the accuracy and sensitivity of rapid intraoperative detection of IDH, TERT, BRAF indicators through a prospective clinical multi-center study. This part includes a total of 300 fresh tiss...
Eligibility Criteria
Inclusion
- 1\. Glioma patients with Informed Consent Form 2. Glioma patients with intact clinical information
Exclusion
- 1\. Glioma patients without Informed Consent Form 2. Glioma patients without intact clinical information
Key Trial Info
Start Date :
August 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
137 Patients enrolled
Trial Details
Trial ID
NCT04904419
Start Date
August 1 2021
End Date
January 31 2022
Last Update
April 18 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Fujian Medical University
Fuzhou, China
2
Huashan Hospital(West campus)
Shanghai, China
3
Huashan Hospital
Shanghai, China
4
General Hospital of Ningxia Medical University
Yinchuan, China